LisaMBalistreriMDM.S.

PubMed

• Hydroxychloroquine Induced Cardiotoxicity: A Case Series.
  Artur Schneider, Jonna Sadhana, Maximiliano Diaz Menindez, Suren Jeveratnam, Lisa Balistreri, Colleen Thomas, Razvan Chirila, Florentina Berianu> ;Romanian Journal of Internal Medicine = Revue Roumaine De Medecine Interne. 2024 Feb 20
• Bilateral Lumbosacral Plexopathy As the Initial Manifestation of Systemic Sarcoidosis: A Case Report.
  Andrés F Cardona-Cardona, Sehreen Mumtaz, Lisa Balistreri, Rupert Stanbourough, Ronald Butendieck, Benjamin Wang, Andy Abril, Majithia Vikas, Florentina Berianu> ;Cureus. 2024 Feb 1
• A Rare Case of Cardiac Tamponade in a Patient With Anti-RNA Polymerase III Scleroderma.
  Artur Schneider, Nikita Jhawar, Lisa Balistreri, Razvan Chirila, Florentina Berianu> ;Cureus. 2023 May 1
• 13 citations
  Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women
  Elizabeth A. Comen, L. Balistreri, Mithat Gonen, Ana Dutra-Clarke, Maurizio Fazio, Joseph Vijai, Zsofia K. Stadler, Noah D. Kauff, Tomas Kirchhoff, Clifford A. Hudis, ...> ;Breast Cancer Research and Treatment. 2011 Jun 1
• 223 citations
  Germline BRCA Mutations Denote a Clinicopathologic Subset of Prostate Cancer
  David J. Gallagher, Mia M. Gaudet, Prodipto Pal, Tomas Kirchhoff, Lisa Balistreri, Kinjal C. Vora, Jasmine Bhatia, Zsofia K. Stadler, Samson W. Fine, Victor E. Reuter,...> ;Clinical Cancer Research. 2010 Apr 1
• 16 citations
  Mismatched base pair simulations for ASFV Pol X/DNA complexes help interpret frequent G•G misincorporation
  Benedetta Sampoli Benitez, Karunesh Arora, Lisa Balistreri, Tamar Schlick> ;Journal of Molecular Biology. 2008 Dec 31
• Join now to see all

Abstracts/Posters

• Evaluation of the potential clinical utility of risk models incorporating genomic risk information
  Comen EA, Balistreri L, Kirchhoff T, Gaudet M, Dutra-Clarke AV, Offit K, Robson ME, 2010 ASCO Annual Meeting Proceedings, 6/2010
• Breast Cancer Risk Single Nucleotide Polymorphism (SNP) Genotypes Do Not Correlate with Risk Estimates from Existing Prediction Models
  Comen E, Balistreri L, Kirchhoff T, Gaudet M, Dutra Clark A, Hudis C, Offit K, Robson M, CTRC-AACR San Antonio Breast Cancer Symposium, 12/2009
• Breast cancer risks in individuals testing negative for known family mutations in BRCA1 or BRCA2
  Domchek SM, Gaudet MM, Stopfer JE, Kemel Y, Powers J, Balistreri L, Tigges-Cardwell J, Nathanson KL, Offit K, Robson ME, Journal of Clinical Oncology, 2009 Annual Meeting Proceedings, 5/2009
• Prevalence of BRCA1 and BRCA2 mutations in Jewish women with triple negative breast cancer.
  Comen EA, Davids M, Kirchhoff T, Balistreri L, Hansen J, Kosarin K, Offit K, Robson ME, 2008 ASCO Annual Meeting Proceedings, 5/2008
• Adherence to mammogram (MMG) screening guidelines in BRCA1/2 mutations carriers
  Goldfrank DJ, Lee J, Kauff ND, Hurley KE, Balistreri LM, Hellawell J, Borgen PI, Hudis CA, Offit K, Robson ME, 2005 ASCO Annual Meeting Proceedings, 6/2005
• Prevalence of BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish (AJ) families with breast cancer (BC) and pancreatic cancer (PC)
  Marcotrigiano MC, Wadsworth E, Balistreri L, Schluger A, Offit K, Robson M, 2005 ASCO Annual Meeting Proceedings, 6/1/2005
• Impact of intensive MRI surveillance in BRCA1/2 carriers
  Hurley K, Balistreri L, Wedderburn W, Offit K, Robson M, Annals of Behavioral Medicine, 4/2005
• Join now to see all